dsm-firmenich restructures executive committee to drive growth in nutrition and health

The company is evolving the structure of its Executive Committee to sharpen its focus on high-growth, high-margin segments while leveraging its strengths

dsm-firmenich has announced significant changes to its executive committee, effective 1 September 2025. This restructuring is designed to sharpen the company's focus on high-growth, high-margin segments, aligning with the growing consumer demand for holistic wellbeing solutions.

Alessandre Keller will join the company on September 22, 2025. As of January 1, 2026, Alessandre will take on the role of President of Health, Nutrition & Care (HNC), succeeding Philip Eykerman, who will take on the role of Chief Strategy, M&A and Transformation Officer as of January 1, 2026, remaining a member of the Executive Committee.

Alessandre (newly appointed as a member of the Executive Committee) is a Swiss national with over 25 years of global leadership experience spanning China, Asia-Pacific, Europe, the Middle East, and Latin America. He brings a combination of strategic vision and operational excellence across the healthcare, nutrition, and FMCG sectors. From pioneering innovation at Nestlé to steering Unilabs’ business through transformational growth and pandemic-era resilience, Alessandre is a proven force for progress.

Maurizio Clementi will become President of Taste, Texture & Health (TTH) on January 1, 2026, following the forthcoming retirement of Patrick Niels, who will step down after a distinguished 34-year career with the company.

Maurizio (newly appointed as a member of the Executive Committee), a US-Italian citizen, has been working alongside Patrick Niels as the EVP for Taste since the creation of dsm-firmenich and is ideally placed to lead the TTH business into its next chapter. Maurizio has been with the company for the past 14 years and held senior roles in the field of Taste. Maurizio is known for his broad expertise and passion across multiple industries, and in building high-performing, customer-focused teams.

As the company is preparing the final stages of the Animal Nutrition & Health carve-out, Ivo Lansbergen, President ANH, will fully focus on leading the ANH business with his leadership team and will step down from the dsm-firmenich Executive Committee on October 1, 2025. He will continue to report to Dimitri de Vreeze, Chief Executive Officer.

Philip Eykerman, currently holding the role of President of Health, Nutrition & Care, will remain on the Executive Committee as Chief Strategy, M&A and Transformation Officer. 

Patrick Niels will retire from dsm-firmenich at the end of 2025 after more than three decades of impactful performance and service.